Nubexa Retatrutide + Cagrilintide Research Blend

This is a pre-mixed research blend combining Retatrutide (triple agonist GLP-1/GIP/Glucagon, 5mg) with Cagrilintide (long-acting amylin analog, 5mg) — representing cutting-edge metabolic research combinations.

— Mechanism Of Action

The combination engages four metabolic pathways: GLP-1, GIP, glucagon, and amylin receptors. This is the most pharmacologically diverse metabolic peptide combination currently in research.

— Research Applications

Used in: advanced metabolic research, multi-pathway metabolic studies, comparative complex metabolic combinations.

— Product Specifications

Compound	Retatrutide + Cagrilintide Research Blend
Available Strengths	10mg
Purity	≥99% (verified by HPLC)
Form	Lyophilized powder
Storage	-20°C, protected from light
Reconstitution	Bacteriostatic water (sold separately)
Shelf Life	36 months (lyophilized, properly stored)
Certificate of Analysis	Available upon request — contact us

— What’s Included

Sealed lyophilized vial(s) of Retatrutide + Cagrilintide Research Blend
Lot number and product information
Discreet, temperature-controlled packaging
Tracked international shipping

⚠ FOR RESEARCH USE ONLY
This product is sold strictly for laboratory research purposes. Must be 21 years or older to purchase. By placing this order you confirm that you are a qualified researcher or representative of a research organization purchasing this material exclusively for in vitro research applications.

Nubexa Retatrutide + Cagrilintide Research Blend

— Mechanism Of Action

— Research Applications

— Product Specifications

— What’s Included

Reconstitution

Storage

Disclaimer